The Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
NCT Number: NCT02808689
This is a pilot, proof of concept, early stage study. The study goal is to determine whether the Functional Medicine approach to the treatment of moderate to severe persistent asthma enhances standard guideline-based care with respect to asthma outcomes.
Looking for future studies?
Notify Me19 year–65 year
All sexes
Interventional
Not applicable
Cleveland, Ohio, 44195, United States
Functional Medicine is a holistic approach to treating chronic conditions by attempting to address the underlying causes of chronic disease states. The purpose is to address the whole person, not just a set of symptoms. The patient care involves evaluating the interactions among genetic, in-utero, and lifetime environmental exposures. In addition, Functional Medicine specialists also aggressively address lifestyle factors such as nutrition and exercise that influence long-term health and chronic diseases. By doing so, the intention is to reduce ongoing biologic imbalances from deficiencies in dietary oxidants/antioxidants via vitamin supplementation, hormonal imbalances through evaluation and management, and the need for medications with unwarranted side effects that compound the chronic medical conditions and adverse effects (e.g. excess use of antibiotics), and to systematically evaluate intolerances to certain foods and additives.
Collaborating with Functional Medicine directly addresses the Guideline focus on control of factors contributing to symptom exacerbation as well as the Cleveland Clinic care path initiative goals of improving patient satisfaction with collaborative healthcare teams to modify risk factors and counsel on environmental/lifestyle modifications. This study will look at the effectiveness of adding a Functional Medicine approach to patient asthma care.
The investigators intention with this pilot study is to study subjective areas of medicine (symptoms and quality of life) as objectively as possible, in order to supplement asthma care guidelines with potential evidence of asthma-related quality of life, lung function/asthma control, and biomarker-based reduction of inflammation and improvement of immune status. Certainly there is value to both approaches and the aspects that are valuable need to be determined so that these two disciplines can have a more integrated approach moving forward and benefit a larger population in innovative and scientifically proven ways.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Will look at nutrition and exercise that influence long-term health and chronic diseases.
Reduce ongoing biologic imbalances from deficiencies in dietary oxidants/ antioxidants via vitamin supplementation. Approach is customized based on results for laboratory testing.
Use of asthma care guidelines set forth by the National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI) and Global Initiative for Asthma
Time frame: 9 Months
Measured by Asthma Control Test Questionnaire (ACQ)
Time frame: 9 Months
Measured by Asthma Quality of Life Questionnaire (AQLQ)
Time frame: 9 Months
Spirometry measures of forced expiratory volume at one second (FEV1) and forced vital capacity (FVC)
Time frame: 9 Months
Bronchodilator response, specific airway conductance (% SGaw) and specific airway resistance (SRaw)
Time frame: 9 Months
Peak flow measured twice daily and recorded in a diary
Time frame: 9 months
Measurement of exhaled Nitric Oxide
Time frame: 9 months
Total inhaled corticosteroid (ICS) dose
The Cleveland Clinic
Other
Acronym: FAst
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01760915
Asthma, Bronchial Diseases
Madison, Wisconsin, United States
View Trial DetailsNCT02517099
Asthma, Bronchial Diseases
London, United Kingdom
View Trial DetailsNCT03797404
Asthma, Bronchial Diseases
Paris, France
View Trial DetailsNCT01898767
Asthma, Bronchial Diseases
Madison, Wisconsin, United States
View Trial Details